Kalkine has a fully transformed New Avatar.

mid-cap

Should Investors Exit From This NYSE-Listed Tech Major - WEX

Feb 04, 2022 | Team Kalkine
Should Investors Exit From This NYSE-Listed Tech Major - WEX

WEX Inc.

WEX Inc. (NYSE: WEX) is a provider of financial technology services. Its current reportable segments are Fleet Solutions, Travel and Corporate Solutions, and Health and Employee Benefit Solutions. The Health and Employee Benefit Solutions business earns the vast majority of its income by selling consumer-directed healthcare payment products and processing via its US Software as a Service (SaaS) platforms.

Why Should Investors Exit?

  • Leveraged Balance Sheet: At the end of September 30, 2021, the company's debt to equity ratio was 1.62x, which was too high compared to the industry norm of 0.50x. Furthermore, its long-term debt to Total Capital ratio was 55.8%, compared to the industry norm of 26.0%. This reflects the fact that the company is exposed to greater balance-sheet risk.
  • High Average Payables and Receivables Days: In comparison to the industry, the company has a high average Accounts Payable days, implying that it takes longer to pay its suppliers. Payable days were 649.4 days at the end of September 30, 2021, compared to the industry median of 35.9 days. Furthermore, the firm also takes longer to receive payments from its customers. At the end of September 30, 2021, the company's average receivable days were 584.2 days, compared to the industry mean of 65.4 days.
  • Technical Weakness: On the daily chart, WEX prices sustain above the horizontal trend line support zone and take the same support. Moreover, the momentum oscillator RSI (14-period) trading at ~59.56, reversing from the higher levels. However, On the weekly charts, the prices are trading below the trend-following indicators 50- period SMA, which may act as a resistance level for the stock.

Valuation Methodology: Price/Earnings Per Share Multiple Based Relative Valuation

(Analysis by Kalkine Group)

* % Premium/(Discount) is based on our assessment of the company's NTM trading multiple after considering its key growth drivers, economic moat, stock's historical trading multiples versus peer average/median, and investment risks.

Stock Recommendation:

In the past nine months, WEX stock price has fallen 20.06% and might fall even further from current levels to its 50 days moving average. We have valued the stock using the Price/Earnings-based relative valuation methodology and arrived at a target price of USD 142.25.

Considering the company's leveraged balance sheet risk, significantly high payable and receivable days, current valuation, and other technical indicators, we recommend a "Sell" rating on the stock at the current price of USD 158.80, down 2.29%, as of February 02, 2022, at 11:54 AM ET.

 

Three-Year Technical Price Chart (as of February 03, 2022; 11:54 AM ET). Analysis by Kalkine Group

* The reference data in this report has been partly sourced from REFINITIV.

* All forecasted figures and industry information have been taken from REFINITIV.


Disclaimer - This report has been issued by Kalkine Pty Limited (ABN 34 154 808 312) (Australian financial services licence number 425376) (“Kalkine”) and prepared by Kalkine and its related bodies corporate authorised to provide general financial product advice. Kalkine.com.au and associated pages are published by Kalkine.

Any advice provided in this report is general advice only and does not take into account your objectives, financial situation or needs. You should therefore consider whether the advice is appropriate to your objectives, financial situation and needs before acting upon it.

There may be a Product Disclosure Statement, Information Statement or other offer document for the securities or other financial products referred to in Kalkine reports. You should obtain a copy of the relevant Product Disclosure Statement, Information Statement or offer document and consider the statement or document before making any decision about whether to acquire the security or product.

You should also seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice) as necessary before acting on any advice in this report or on the Kalkine website. Not all investments are appropriate for all people.

The information in this report and on the Kalkine website has been prepared from a wide variety of sources, which Kalkine, to the best of its knowledge and belief, considers accurate. Kalkine has made every effort to ensure the reliability of information contained in its reports, newsletters and websites. All information represents our views at the date of publication and may change without notice.

Kalkine does not guarantee the performance of, or returns on, any investment. To the extent permitted by law, Kalkine excludes all liability for any loss or damage arising from the use of this report, the Kalkine website and any information published on the Kalkine website (including any indirect or consequential loss, any data loss or data corruption). If the law prohibits this exclusion, Kalkine hereby limits its liability, to the extent permitted by law, to the resupply of services.

Please also read our Terms & Conditions and Financial Services Guide for further information.

On the date of publishing this report (referred to on the Kalkine website), employees and/or associates of Kalkine and its related entities do not hold interests in any of the securities or other financial products covered on the Kalkine website unless those persons comply with certain safeguards, procedures, and disclosures.

Kalkine Media Pty Ltd, an affiliate of Kalkine Pty Ltd, may have received, or be entitled to receive, financial consideration in connection with providing information about certain entity(s) covered on its website.